Sign Up to like & get
recommendations!
0
Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2440_10
Abstract: FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. A. Chiappella* | C. Carniti | M. Ceccarelli | M.G. Cabras | A. Re | F. Salvi |…
read more here.
Keywords:
behalf fondazione;
hematology;
fondazione italiana;
fil ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Acta Mathematica Hungarica"
DOI: 10.1007/s10474-019-00919-4
Abstract: Abstract The order dual $${[{\rm Fil}{R_{R}}]^{{\rm du}}}$$[FilRR]du of the set $${{\rm Fil}{R_{R}}}$$FilRR of all right topologizing filters on a fixed but arbitrary ring R is a complete lattice ordered monoid with respect to the (order…
read more here.
Keywords:
mathfrak;
fil;
lattice;
fil filrr ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Talanta"
DOI: 10.1016/j.talanta.2016.10.031
Abstract: A fully automated on-site device (SAMP-FIL) that enables water sampling with simultaneous filtration and effective cleaning procedures of the device's components was developed and field-tested. The SAMP-FIL was custom-built using commercially available components and was…
read more here.
Keywords:
custom built;
enzymatic activity;
fil;
low cost ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.1191
Abstract: Filgotinib (FIL), a once-daily, oral Janus kinase 1 preferential inhibitor, was approved for the treatment of Ulcerative Colitis (UC) following the phase 2b/3, randomized SELECTION clinical trial.1 Real-world data on the effectiveness and safety of…
read more here.
Keywords:
effectiveness safety;
fil;
real world;
fil fil ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2323
Abstract: Background Filgotinib (FIL), an oral, selective Janus kinase 1 (JAK1) inhibitor, significantly improved the signs and symptoms of rheumatoid arthritis (RA) in the phase 3 FINCH2 study in bDMARD-IR patients with active RA.1 Objectives To…
read more here.
Keywords:
fil;
region;
ltd;
fil 200 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2509
Abstract: Background Filgotinib (FIL), an oral selective JAK1 inhibitor, was safe and efficacious in FINCH2, a randomized, double-blind, placebo-controlled, phase 3 study in patients with active rheumatoid arthritis (RA) who had an inadequate response to biologic…
read more here.
Keywords:
gilead sciences;
sciences inc;
gilead;
fil ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Synthesis"
DOI: 10.24215/1851779xe139
Abstract: La cuestión, tan cara al mundo grecorromano, de las formas de vida es desarrollada por Filón de Alejandría en diversos tratados, en los que se acerca y define la distinta tipología en la que el…
read more here.
Keywords:
fil alejandr;
fil;
contemplativa;
vida rica ... See more keywords